Pharmafile Logo

Data, Evidence, Education: Tackling the Global Multi‑Trillion‑Dollar Rare Disease Burden

- PMLiVE

Rare diseases are individually uncommon, yet together they affect an estimated 300 million+ people worldwide and touch the lives of over one billion when families and caregivers are included. For the >7,000 distinct rare conditions, around 70% of which begin in childhood, many patients and families face common challenges including delayed diagnosis, fragmented care, and significant social and financial burdens. A recent World Economic Forum white paper, “Making Rare Diseases Count: How Better Data Can Unlock a Multi‑Trillion‑Dollar Opportunity,” argues that these conditions represent not only a profound human challenge, but also one of the largest untapped opportunities in global health and economic resilience.

Access the whitepaper here

The paper highlights the massive but largely invisible cost of rare diseases, estimated at between USD 7.2 and 8.6 trillion each year, and calls for stronger data systems to make this burden visible and actionable. Its roadmap centres on five priorities: defining a minimum dataset across countries, strengthening patient registries, expanding screening and diagnostic capacity, enabling trusted data sharing, and using AI and digital tools to close evidence gaps.

This agenda builds on growing policy momentum, including the pivotal 2025 World Health Assembly resolution on rare diseases, sponsored by Egypt and Spain and co‑sponsored by 39 other UN Member States, which includes a call to member states to support education for healthcare providers on rare diseases. Shortening the diagnostic odyssey through education is crucial: today, only 19% of physicians feel confident diagnosing rare diseases, and many patients wait years for an accurate diagnosis.

Access the whitepaper here

Medscape, as a contributor to the WEF paper, brings evidence that targeted professional education can help close this gap. Its rare disease programmes, informed by global survey data and real‑world outcomes, have shown that clinicians who participate in accredited training as compared with similar cohorts who do not, order significantly more genetic tests and code more often for rare diseases. This suggests that education may help shorten the diagnostic journey in real world practice. Medscape data also reveal striking gaps in physician awareness of rare disease prevalence, with a majority reporting that they never or rarely (defined as 1-2x per year), see rare disease patients despite evidence suggesting they should be seeing several per week.

With a community of >13 million healthcare professionals and the largest dedicated library of rare disease education, Medscape is positioned to translate the WEF’s data‑driven roadmap into everyday clinical practice. By aligning better data with focused education, the rare‑disease community can turn global recognition into earlier diagnoses, better access to care, and measurable value for patients, health systems, and societies worldwide.

To learn more about how Medscape Education is tackling the rare disease burden through precision education, please contact S Christy Rohani‑Montez.

Sign up to Medscape Education’s Rare Disease Newsletter here.

About Medscape Education

Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses for physicians, nurses, and other healthcare professional

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Being Rare Together: Medscape Education Sponsors the 2025 Cholestatic Liver Disease Summit

Medscape Education is a proud sponsor of the inaugural 2025 Cholestatic Liver Disease Summit, taking place June 26–28 in Aurora, Colorado, at the Hyatt Regency Aurora-Denver Conference Center. Hosted in...

New Alzheimer’s Treatments Are Driving a Shift in Earlier Detection and Clinician Education Engagement

June is Brain and Alzheimer’s Awareness Month — a chance to examine real-world data that links new treatments to changing clinical behavior.

“Humanizing Healthcare, Humanizing Education: The Power of Patient Integration”

Victoria Harvey-Jones, PhD, Clinical Strategist (Oncology) and Worldwide Patient Integration Lead to Present at the 2025 Patient Centricity & Engagement Conference

Driving Impact in Diabetes Care: Medscape to Present 11 Publications at ADA’s 85th Scientific Sessions

Medscape Education is proud to present 11 publications at the American Diabetes Association 85th Scientific Sessions, taking place June 20–23 in Chicago. These presentations reflect our commitment to advancing diabetes care...

Medscape Education Celebrates 30 Years of Impact with Launch of The Center of Excellence for Instructional Design

Medscape Education, a global leader in healthcare education, proudly announces the official launch of its Center of Excellence for Instructional Design—a central hub of expertise and strategic capability, dedicated to...

Medscape at the American Diabetes Association’s 85th Scientific Sessions: Your Sweet Spot for Innovation!

The American Diabetes Association’s 85th Scientific Sessions is almost here, and Medscape is ready to make an impact in the world of diabetes care! With two groundbreaking symposia, 11 dynamic...

Sharing Educational Outcomes at EHA 2025

Medscape Hematology will be at EHA 2025 to showcase the power of education impact through online abstracts, posters, and 4 symposia.

30 Years of Innovation in Education at HLTH Europe

The Medscape Education Global team will be travelling to Amsterdam for the HLTH Europe 2025 conference to showcase the power and value of CME. As pioneers in clinician education for...

Medscape Online Continuing Medical Education Led to New Diagnoses in Alzheimer’s Disease

Medscape Education has recently published a study looking at the real-world impact of online continuing medical education on Alzheimer's disease diagnosis. Read the full article here.  The study, published in...

Medscape Oncology at ASCO 2025: Driving Innovation, Education & Better Patient Outcomes

Medscape Oncology is making a powerful impact at ASCO 2025, bringing seven high-impact symposia, new research insights, and the return of the Medscape Fellows Program—all aimed at educating the next...